REFERENCES
- Antommaria, M., A. H. Gibb, T. S. McGuire, et al. 2020. Ventilator triage policies during the COVID-19 pandemic at U.S. hospitals associated with members of the Association of Bioethics Program Directors. Annals of Internal Medicine. doi:10.7326/M20-1738.
- Emanuel, E. J., D. Wendler, and C. Grady. 2000. What makes clinical research ethical? JAMA 283(20): 2701–2711. doi:10.1001/jama.283.20.2701.
- Frye, III. J. W. 2018. Perverse effects: How insufficient guidance to IPFs can undermine both research and health outcomes of clinical trials. The American Journal of Bioethics 18(4): 78–80. doi:10.1080/15265161.2018.1444822.
- Jecker, N. S., A. G. Wightman, A. R. Rosenberg, and D. S. Diekema. 2018. Ethical guidance for selecting clinical trials to receive limited space in an immunotherapy production facility. The American Journal of Bioethics 18(4): 58–67. doi:10.1080/15265161.2018.1444817.
- London, A. J., and J. Kimmelman. 2020. Against pandemic research exceptionalism. Science 368(6490): 476–477. doi:10.1126/science.abc1731.
- Malley, R., and M. Lipsitch. 2020. “Treating Mild Coronavirus Could Help Save Everyone” New York Times, May 22, 2020.
- Milleson, V. 2018. Prioritizing facts and values in immunotherapy trial selection: Some further guidance. The American Journal of Bioethics 18(4): 76–78. doi:10.1080/15265161.2018.1444821.
- Savin, K., and L. Guidry-Grimes. 2020. Confronting disability discrimination during the pandemic. The Hastings Center Bioethics Forum Essay, April 2. https://www.thehastingscenter.org/confronting-disability-discrimination-during-the-pandemic/ (accessed May 22, 2020).
- Shah, S. K., F. G. Miller, T. C. Darton, et al. 2020. Ethics of controlled human infection to address COVID-19. Science 368(6493): 832–834. doi:10.1126/science.abc1076.
- Smirnoff, M., I. Wilets, D. F. Ragin, et al. 2018. A paradigm for understanding trust and mistrust in medical research: The Community VOICES study. AJOB Bioethics 9 (1):39–47. doi:10.1080/23294515.2018.1432718.